New branded drugs helping Teva Pharm move closer to growth
Teva Pharmaceutical: 2023 Could Finally Be The Stock's Breakout Year (NYSE: TEVA) | Seeking Alpha
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe - Bloomberg
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
TEVA - Teva- Pharmaceutical Industries Ltd. - ADR Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
$40 million incentive lures global pharmaceutical giant to Parsippany
TEVA - Teva- Pharmaceutical Industries Ltd. - ADR Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Teva Pharmaceutical legal settlements 2014-2022 | Statista
Teva to pay $225M to settle cholesterol drug price-fixing charges | CBS 42
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva earmarks $200M for possible price-fixing settlement with US
TEVA: A Pharma Stock to Watch | Mish's Market Minute | StockCharts.com
Teva Settles Price Fixing Charges With U.S. DOJ
TEVA Stock Sees Positive Momentum as Bank of America Analyst Maintains Strong Buy Rating | WallStreetZen
Teva Selling $3.5 Billion of Junk Bonds to Refinance Debt - Bloomberg
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal | Markets Insider
Teva Pharmaceuticals to Pay $225M for Price-Fixing | powderbulksolids.com
TEVA Pharmaceutical Sell-Off, is it Time to Buy, Sell or Hold? – PGM Capital
Teva settles DOJ price-fixing case for $225M, plus product divestiture (NYSE:TEVA) | Seeking Alpha
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Suffering from missteps, drugmaker Teva struggles to heal own ills - The Times of Israel
TEVA stock higher as Bank of America welcomes opioid deal with West Virginia (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals, Alvotech Expand Strategic Biosimilars Pact | Contract Pharma
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View - Barrons
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
